Roundtable: Investors Forum

As an element of the Westchester Biotech Blueprint 2030 program, we are convening thought leaders at the forefront of regional/international cluster building.

The specific interests and concerns of investors in the life sciences -- including diagnostics, and devices -- reflect the complexity and impact of biomedical research itself.

This is a by-invitation platform for sharing perspectives, helping inform our initiatives, and addressing common challenges that may express themselves in unique ways across the landscape.

In alignment with the rest of Blueprint 2030, we provide cross-silo discussions to build infrastructure — and opportunity — for investment in regional commercialization with international impact.

-Venture Philanthropy
-Post-Seed Funding for Life Science Companies
-Rare Disease Research Hub
-Westchester Big Data Hub
-Cross-silo Collaboration Models
-Government Perspectives


For an invitation contact


Jonathan Bandel, Assistant Vice President
Strategic Service Lines, White Plains Hospital

Michael Welling, Co-Founder, and Chief Strategy Officer,
Westchester Biotech Project
Partner, Meridian Risk Management